Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org
 

A Phase 1 (First-In-Human [FIH]), Multi-Site, Dose Escalation and Expansion Study of WTX-330 in Adult Patients with Advanced or Metastatic Solid Tumors or Lymphoma

Principal Investigator: Fountzilas, Christos

A Phase 1 Study of ASP3082 in Participants with Previously Treated Locally Advanced or Metastatic Solid Tumor Malignancies with KRAS G12D Mutation

Principal Investigator: Fountzilas, Christos

A022004:RANDOMIZED TRIAL OF CONSOLIDATION TARGETED ADJUVANT THERAPY WITH ENCORAFENIB AND CETUXIMAB VERSUS USUAL CARE FOR PATIENTS WITH STAGE II/III BRAF V600E COLON CANCER

Principal Investigator: Krishnamurthy, Anuradha

A Phase 0 Study of EGF-depleting therapy CIMAvax-EGF in Combination with Standard Therapy for RAS- and BRAF wild-type Metastatic Colorectal Cancer

Principal Investigator: Vadehra, Deepak

EA2176 A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naïve Metastatic Anal Cancer Patients

Principal Investigator: Mukherjee, Sarbajit

S2107 Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer

Principal Investigator: Vadehra, Deepak

A022104:THE JANUS RECTAL CANCER TRIAL: A RANDOMIZED PHASE II/III TRIAL TESTING THE EFFICACY OF TRIPLET VERSUS DOUBLET CHEMOTHERAPY REGARDING CLINICAL COMPLETE RESPONSE AND DISEASE-FREE SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER

Principal Investigator: Vadehra, Deepak